baber/WOPTO huggingface dataset:
Patent NZ-337213-A (NZ)
Title: Multiplicative combining of cable joint discharge filtered sensor signals
Inventor: ERIKSSON THOMAS
IPC: G01R31/12
Filed: 1998-03-09
Abstract: A device for sensing electric discharges in a test object 1 such as a cable joint with two electric connection conductors 1a, 1b, 1c, 1d, includes at least one of first and second sensors 2a, 2b and evaluation equipment EVU.  Each one of the sensors generates and supplies to the evaluation equipment sensor signals v1, v2 in dependence on current pulses through the connection conductors and the direction thereof.  The sensors are separated by a distance L1 corresponding to a time period for sensor signals originating from a current pulse passing through the cable joint. The evaluation equipment generates in dependence on the received sensor signals an indication signal IND, indicating an electric discharge in the test object. The evaluation equipment includes first and second tuning units T1, T2 respectively associated with the first and second sensors, each unit, in dependence on the respective sensor signal, forming a first filter signal SF1 and a second filter signal SF2, respectively, periodically oscillating with a preselected period TP, and a multiplier MU, which is supplied with, and in dependence on said filter signals, forms a product signal SP, whereby the evaluation equipment forms the indication signal in dependence on the product signal.
Patent NZ-503860-A (NZ)
Title: Method and apparatus for treating an article containing an oxidizable organic compound and an organoleptic compound
Inventor: BECRAFT MICHAEL L
IPC: C08J7/18
Filed: 1998-10-21
Abstract: A method of treating an article containing an oxidisable organic compound by exposing it to actinic radiation and then treating it with a treating medium, thereby reducing the exposure of the oxygen sensitive products to oxygen while also reducing the amount of by-product extractables.
Patent NZ-504801-A (NZ)
Title: A medicament containing one type of xanthophylis for the prophylactic treatment of mastitis
Inventor: LIGNELL AKE
IPC: A61K31/122
Filed: 1998-12-10
Abstract: A method of prophylactic treatment of mastitis in mammalian subjects, including human mothers, is described.  The method comprises administration of a prophylactically effective dose of a human or veterinary medicament containing at least one type of xanthophylls, such as astaxanthin.  Preferably, the astaxanthin exists in a form esterified with fatty acids, e.g. in the form of algae meal produced by culturing of Haematococcus sp.  The effective dosage of the medicament contains 0.01 to 1 mg astaxanthin per kg body weight per day.
Patent NZ-506989-A (NZ)
Title: Fizzy formulations for an alkali sensitive active agents containing organic edible acid and an alkaline earth carbonate
Inventor: PISKERNIG MARIA ANDRE
IPC: A61K31/135
Filed: 1999-03-20
Abstract: An effervescent, rapidly disintegrating oral dosage form of (a) an alkali-sensitive active ingredient, (b) an effervescent base comprising at least one of (i) at least one alkaline earth metal carbonate, (ii) an organic edible acid, and (iii) an alkali metal salt of citric acid, and optionally (c) a pharmaceutically acceptable auxiliary ingredient.
Patent NZ-507822-A (NZ)
Title: Thermoplastic film with good interply adhesion
Inventor: PIPER GRAHAM R
IPC: B32B27/32
Filed: 1999-05-13
Abstract: A multilayer film comprising: i) An outer layer which comprises a polymer comprising mer units derived from propylene; and ii) Directly adhered to the outer layer, a second layer comprising a homogeneous ethylene/a-olefin interpolymer having a density of no more than 0.915 g/cm3. The film is orientated, and has a free shrink at 85oC of at least 5% in at least one direction.  The homogeneous ethylene/a-olefin interpolymer is cross-linked to the extent that the second layer does not delaminate from the first layer after two hours submersion in water at 65oC. Also described is a bag comprising a multilayer film as described above, where the outer layer comprising a polymer comprising mer units derived from propylene is sealed to itself so as to form a bag, where the outer film layer becomes the inside layer of the bag. Also described is method of packaging a food product comprising: i) Substantially completely surrounding the food product in a multilayer film as defined above. ii) Sealing the film to itself so as to form a packaged food product. iii) Subjecting the packaged film product to an elevated temperature sufficient to cook the food product. Also described is a food product packaged by the method described above.
Patent NZ-509308-A (NZ)
Title: Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
Inventor: RENZI PAOLO
IPC: A61K38/00
Filed: 1999-06-17
Abstract: An antisense oligonucleotide with sequences disclosed, directed against a nucleotide sequence coding for a common subunit of the IL-3, IL-5 and GM-CSF receptors.  A composition comprising said oligonucleotide for use in treating asthma, allergy and inflammation.
Patent NZ-513466-A (NZ)
Title: A subsurface pipeline inspection probe
Inventor: CULL JAMES PHILLIP
IPC: G01N27/72
Filed: 2000-01-13
Abstract: An inspection system (1) is disclosed. The inspection system (1) comprises a transmitter (10) and a receiver (40) configured for communication with a remotely positioned processing means (80). The transmitter (10) and receiver (40) are arranged as a mobile apparatus (15) configured for insertion into any duct, conduit, pipeline, mining shaft, or the like, of any diameter or cross section. The transmitter (15) is configured to transmit an electromagnetic signal to induce an electromagnetic response in the duct and the electromagnetic response is detected by the receiver. The mobile apparatus (15) is self-powered and processes the electromagnetic response prior to communicating the processed response to the remotely positioned processing means (80) as a discrete signal
Patent NZ-518398-A (NZ)
Title: Oral formulations for anti-tumor compounds
Inventor: MUGGETTI LORENA
IPC: A61K31/337
Filed: 2000-10-02
Abstract: The present invention relates to a semi-solid filling medium which comprises a camptothecin derivative; a pharmaceutically acceptable carrier matrix which is a polyglycolized glyceride; and an effective thickening-reducing and stabilisation-promoting amount of one or more pharmaceutically acceptable excipients chosen from a lecithin, a phospholipid, a pharmaceutically acceptable oil, a polyethylglycol and a saturated or unsaturated mono-, di- or triglyceride.
Patent NZ-523517-A (NZ)
Title: A receiver beam and an inclined roof assembly containing the receiver beam
Inventor: WOOLF KEITH
IPC: E04B7/04
Filed: 2003-01-07
Abstract: An elongate receiver beam (21) for connecting at least one inclined roof member (31) to at least one second roof member, the receiver beam (21) comprising an inclined first land (35) disposed on top of the receiver beam (21), a sidewall (36) having a second land (45) extending therefrom for supporting a second roof member, and a dependent flange (41) for engagement with a valley beam (19) in a roofing assembly.
Patent NZ-524656-A (NZ)
Title: Surfactant composition for gypsum boards
Inventor: MARTIN DANIEL
IPC: C09K23/02
Filed: 2001-09-14
Abstract: A gypsum plaster composition comprising in combination with plaster and water, a surfactant composition is disclosed, wherein surfactant composition comprises alkylsulphates of formula H(CH2)nOSO3-M+, wherein: n is from 6 to 16 and the average number of carbon atoms in the alkylsulphate composition nm ranges between 10 and 11, and M is a monovalent cation. A method for preparing the plaster composition and a gypsum plaster board from the said composition is also disclosed. The composition is suitable for producing lightened gypsum plaster boards.
Patent NZ-528952-A (NZ)
Title: Particles of HCV envelope proteins: use for vaccination
Inventor: DEPLA ERIK
IPC: C12N7/01
Filed: 1999-06-23
Abstract: An oligomeric particle consisting of purified HCV envelope proteins wherein at least one cysteine residue is alkylated is disclosed, where the envelope proteins are one or more envelope proteins selected from the group consisting of E1, E2, part of E1 and part of E2 and having a diameter of 5 to 100 nanometer. These oligomeric particles are used for the manufacture of a medicament to prophylactically induce immunity against HCV. (62) Divided out of 508797
Patent NZ-531755-A (NZ)
Title: Needleless drug delivery using a pioneer projectile
Inventor: POTTER CHARLES DAVID OGILVY
IPC: F42B12/54
Filed: 2002-09-10
Abstract: A pioneer projectile, capable of penetrating a human or animal's skin to thereby facilitate the injection of at least one following therapeutic compound or therapeutic compound containing formulation in a contained state is disclosed, which includes: (i) A first 'penetrating' face which in use penetrates the human or animals skin; and (ii) Remote from the first face a second 'driven' face which in the course of injection is the face upon which a driving force is exerted through the contained therapeutic compound or therapeutic compound containing formulation; characterised in that said pioneer projectile has a width of less than 3mm and an aspect ratio (width to height) of less than 1:4, wherein the pioneer projectile is water soluble, lipid soluble or otherwise biodegradable.
Patent NZ-531985-A (NZ)
Title: Manipulation of flavonoid biosynthesis in Trifolium repens (white clover), Lolium perenne (ryegrass) and Festuca (fescue)
Inventor: SPANGENBERG GERMAN
IPC: C12N15/29
Filed: 2002-10-04
Abstract: A substantially purified or isolated nucleic acid encoding BANYULS (BAN) and its polypeptide from a clover (Trifolium) species are described. The BANYULS gene encodes a anthocyanidin reductase. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify flavonoid biosynthesis, protein binding, metal chelation, anti-oxidation, UV-light absorption, pigment production, plant defense to biotic stress or forage quality, or can be used as a molecular marker.
Patent NZ-536045-A (NZ)
Title: Fast estimation of weak bio-signals using novel algorithms for generating multiple additional data frames
Inventor: CAUSEVIC ELVIR
IPC: G10L21/02
Filed: 2003-03-28
Abstract: A method and apparatus for de-noising weak bio-signals that have a relatively low signal to noise ratio is disclosed. An iterative process of de-noising a data set comprised of a new set of frames is used. The method separately performs a non-linear de-noising operation on each of the component frames and combines the resultant de-noised frames to form a combined resultant de-noised input signal.
Patent NZ-536363-A (NZ)
Title: Mixing pump using plural Bernoulli effects
Inventor: TIMNEY BRYSON
Filed: 2004-11-05
Abstract: A mixing pump is disclosed for mixing two or more fluids, the pump having at least two fluid reservoirs and at least one tube system that is in fluid communication with first and second fluid reservoirs. The first fluid is delivered into the first fluid reservoir under pressure and the first tube system is configured to draw in the second fluid from the second fluid reservoir by a Bernoulli effect.
Patent NZ-537094-A (NZ)
Title: Compositions containing difunctional photoinitiators and aminoacrylates
Inventor: HUSLER RINALDO
IPC: B05D3/02
Filed: 2003-07-10
Abstract: Disclosed is a composition comprising: (A) an ethylenically unsaturated compound that contains at least one aminoacrylate; (B) a photo initiator of formula I wherein: A is -O-, -CH2-, -CH(CH3)- or -C(CH3)2-, and R is methyl or trimethyllilyl, and R may in addition be H when A is C(CH3)2; (C) optionally further binders or additives; (D) optionally further photoinitiators or co-initiators. The UV curing system of the type disclosed is useful for the production of pigmented or unpigmented surface coatings, overprint coatings, formulations for printing inks, powder coatings, inkjet inks, fine layers (gel coats), composite materials or glass fibre cable coatings.
Patent NZ-538952-A (NZ)
Title: Water heater having raw fuel jet pilot and associated burner clogging detection apparatus
Inventor: PEART JACOB A
Filed: 2005-03-21
Abstract: A radiant gas burner within the combustion chamber of a water heater has a pilot flame created using a raw fuel jet that impinges on an interior surface portion of a flame holding outer burner wall portion, representatively of a metal wire mesh material, and is mixed within the burner with combustion air delivered thereto from outside the combustion chamber. The resulting fuel/air mixture passes outwardly through the impinged upon mesh wall portion, which functions as a pilot flame stabilizing structure, and is ignited to form a pilot flame on the exterior of the burner body. A thermocouple portion of a clogging detection system senses a change in the pilot flame shape caused by particulate clogging of the metal mesh material and responsively terminates further gas supply to the water heater.
Patent NZ-539311-A (NZ)
Title: Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
Inventor: SOUBRIER FABIENNE
IPC: C07K14/82
Filed: 2003-10-14
Abstract: A prokaryotic recombinant host cell comprising a heterologous replication initiation protein that activates a conditional origin of replication and an extrachromosomal DNA molecule comprising a heterologous therapeutic gene and a conditional origin of replication whose functionality in the prokaryotic recombinant host cell requires a replication initiating protein which is foreign to a host cell.
Patent NZ-541014-A (NZ)
Title: Use of N-desmethylclozapine to treat schizophrenia while increasing the level of activity of a muscarinic receptor
Inventor: WEINER DAVID M
IPC: A61P25/00
Filed: 2004-01-21
Abstract: Disclosed is the use of N-desmethylclozapine in the preparation of a medicament for ameliorating or treating schizophrenia while increasing the level of activity of a muscarinic receptor.
Patent NZ-541266-A (NZ)
Title: DNA encoding proteins participating in fungal cell wall synthesis
Inventor: TSUKAHARA KAPPEI
IPC: A61K31/4725
Filed: 2001-07-06
Abstract: A DNA that encodes a protein having an activity to confer resistance of a fungus or decrease the amount of a GPI-anchored protein in the cell wall of a fungus due to a defect in the function of the DNA. Also disclosed is a method for screening a compound having an antifungal action.
Patent NZ-553746-A (NZ)
Title: Quinolone analogs as cell proliferation inhibitors
Inventor: WHITTEN JEFFREY P
IPC: A61K31/4745
Filed: 2005-09-16
Abstract: Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt or ester thereof, wherein Z1-4 are each C or N, any two adjacent groups B, X, A, or V may form a ring, W is a 5 or 6 membered optionally substituted ring, and the other substituents are as described in the specification. Also disclosed is the use of the above compound for treating a cell proliferative disorder such as a tumor or cancer, a microbial infection, or for inducing cell death or apoptosis. Also disclosed is a method for preparing the above compound.
Patent NZ-554935-A (NZ)
Title: Use of dihydroimidazolones for the treatment of behavioural abnormalities in dogs
Inventor: RUNDFELDT CHRIS
Filed: 2003-10-09
Abstract: Disclosed is the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of anxiety in dogs.
Patent NZ-555184-A (NZ)
Title: Malonamide derivatives as inhibitors of gamma-secretase for the treatment of AlzheimerÆs disease
Inventor: FLOHR ALEXANDER
IPC: A61P25/28
Filed: 2005-12-01
Abstract: Disclosed are 8-oxo-6,7,8,9-tetrahydro-5-oxa-9-aza-benzocyclohepten-7-yl-malonamide compounds of the general Formula I, wherein the substituents are as defined in the specification, pharmaceutically suitable acid addition salts thereof, and optically pure enantiomers, recemates or diastereomers and diastereomeric mixtures thereof. The compounds are useful for the treatment of Alzheimer's disease.
Patent NZ-566722-A (NZ)
Title: Novel pyrimidine carboxamides
Inventor: TADIPARTHI RAVIKUMAR
IPC: C07D239/28
Filed: 2006-09-07
Abstract: Disclosed are pyrimidine carboxamide compounds of the formula (I), their tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts and compositions, wherein suitable ring systems represented by A is selected from phenyl, naphthyl, pyridyl, thienyl and pyrimidinyl, suitable ring systems represented by B is selected from phenyl, naphthyl, pyridyl, thienyl and pyrimidinyl, R, R1, R2, R3, R4, R5, R6 and R8 are defined as in the specification and m and n are integers ranging from 0 to 4, p is an integer of 1 or 2 and q is an integer in the range of 1 to 10. Also disclosed are compositions comprising said compounds and the use of said compound in the manufacture of a medicament to treat pain, inflammation and immunological disorders.
Patent NZ-570710-A (NZ)
Title: Substituted imidazo[2,1-b]thiazole compounds and their use as mGluR5 receptor modulators
Inventor: KUHNERT SVEN
IPC: A61K31/429
Filed: 2007-03-09
Abstract: Disclosed is a substituted imidazo[2,1-b]thiazole compound of formula 1, or a stereoisomer, salt, or solvate thereof, wherein M1 and M2 are each optionally substituted aryl or heteroaryl groups, R3 and R4 are separate groups as described or may form a ring as described, and wherein the other substituents are as described in the specification. Also described is a process for the preparation of the compound, and the use of the compound for treating disorders associated with the mGluR5 receptor.
Patent NZ-573577-A (NZ)
Title: Xanthine derivatives as A2B adenosine receptor antagonists suitable for treating conditions such as asthma and diarrhoea
Inventor: PERRY THAO
IPC: C07D473/06
Filed: 2003-05-06
Abstract: Disclosed are compounds of formulae I and II, wherein X is optionally substituted arylene and the other substituents are as defined in the specification. The compounds are A2B adenosine receptor antagonists suitable for treating conditions such as atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, asthma, inflammatory gastrointestinal tract disorders including diarrhea, and neurological disorders including senile dementia, Alzheimer's disease and Parkinson's disease. (62) Divided Out of 543416
Patent NZ-582512-A (NZ)
Title: Syringe infusion pump for accomodating syringes with different barrel diameters with force sensor aligned with barrel axis
Inventor: FLACHBART ERIC J
IPC: A61M5/145
Filed: 2008-06-11
Abstract: A syringe infusion pump (20) is disclosed for use with a plurality of different syringes having different barrel diameters. The pump comprises a drive head (22) including a force sensor (32) which is positioned to sense the force applied to the plunger by the drive head. A syringe barrel holder (24) is configured to hold each syringe barrel with the barrel axis automatically aligned with the centre of the force sensor (32) for each different diameter syringe barrel.
Patent NZ-594508-A (NZ)
Title: [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
Inventor: MIDDLEMISS DAVID
IPC: A61K31/4162
Filed: 2010-02-09
Abstract: Patent No. 594508 Disclosed is a compound having the structure (I) as well as pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof, such as 4-chloro-3-{ 2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenylamino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl} -phenol and 4-chloro-3-{ 2-[4-(2-piperazin-1-yl-ethoxy)-phenylamino]-[-1,2,4]triazolo[1,5-a]pyridin-6-yl} -phenol.
Patent NZ-601419-A (NZ)
Title: Carrier insert for accommodating and maintaining the biofilm culture of fluid cleaning structures
Inventor: KENYERES ISTVAN
IPC: C02F3/10
Filed: 2011-01-13
Abstract: A carrier insert (2) is disclosed for accommodating and maintaining a biofilm culture in a liquid cleaning structure (1). The structure may be an activated sludge reactor for cleaning sewerage. The insert (2) contains a spatial web (10) made of woven staple fibres, for increased surface area. The web (10) has a plurality of internal woven fabric textile units (11, 12, 13, 14, 15, 16) that join each other at nodal points (20, 21, 22, 23). External woven textile units (17, 18) are situated at the edges (10a) of the web (10) and are connected to a complete nodal point (20, 21, 22, 23) at an internal end (17a, 18a) and are provided with connection points (24, 25) for joining to the structure (1) at an external end (17b, 18b).
Patent NZ-601776-A (NZ)
Title: Slide and shell container having tamper evident seal
Inventor: CHATELAIN LUCAS
IPC: B65D5/38
Filed: 2011-03-23
Abstract: A slide and shell container (10) comprises an outer shell (14) and an inner slide (12) mounted within the outer shell. The outer shell (14) and the inner slide (12) are detachably connected to each other along one or more lines of weakness (54). Upon separation of the outer shell (14) and inner slide (12) along the one or more lines of weakness (54), the inner slide (12) becomes moveable within the outer shell (14) between a closed slide position and an open slide position. Preferably, the two or more lines of weakness (54) define an integral opening strip (56) which is separable from the container in order to separate the outer shell (14) and the inner slide (12). A panel of the inner slide is shaped to pass through a cut out portion of a panel of the outer shell.
Patent NZ-603348-A (NZ)
Title: Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
Inventor: COLLOCA STEFANO
IPC: A61K39/00
Filed: 2010-02-02
Abstract: Disclosed is an isolated polynucleotide that encodes an adenoviral hexon protein or a functional derivative thereof and that is selected from the group consisting of: (a) a polynucleotide encoding a polypeptide having the amino acid sequence according to SEQ ID NO: 22; (b) a polynucleotide encoding the functional derivative of a polypeptide according to SEQ ID NO: 22, wherein said functional derivative comprises the deletion, insertion and/or substitution of not more than 45 amino acid residues; and (c) a polynucleotide encoding a functional derivative having an amino acid sequence which is at least 95% identical over its entire length to the amino acid sequence of SEQ ID NO: 22, wherein the sequence identity is disclosed in the specification. Also disclosed is the use of the polypeptide in the manufacture of a medicament for the therapy or prophylaxis of a disease.
Patent NZ-609186-A (NZ)
Title: Novel anti-cancer agents
Inventor: BURGESS ANTONY WILKS
IPC: C07D403/12
Filed: 2011-10-27
Abstract: Provided are 5-((1,3,5-triazin-2-yl)amino)imidazolidine-2,4-dione derivative compounds of Formula I, where the variables are as described in the specification. Examples of the compounds are 1-[4-(4-aminomethyl-benzylamino)-6-(4-methoxybenzylamino)-{ 1,3,5} -triazin-2-yl-amino]-imidazolidine-2,4-dione and 1-[4,6-Bis-(4-methoxybenzylamino)-{ 1,3,5} -triazin-2-yl-amino]-imidazolidine-2,4-dione. The compounds may be useful in the treatment of cancer.